Triazolam Tablet
FDA Label NDC 70771-1576

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Triazolam (NDC 70771-1576). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1576-1

Triazolam Tablets USP, 0.125 mg

100 Tablets

Rx only

0.125 mg  Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 01)

0.125 mg Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 01)

NDC 70771-1162- 1

Triazolam Tablets USP, 0.25 mg

100 Tablets

Rx only

0.25 mg Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 02)

0.25 mg Label (Fb074b17 C185 44d2 9d5e 2d5836499c3a 02)

* Please review the disclaimer below.